Cargando…
Fast and safe: Optimising multiple sclerosis infusions during COVID-19 pandemic
Background: The COVID-19 pandemic challenges multiple sclerosis services to be innovative in delivering infusible therapies. To reduce time in clinical settings, and potential staff or space losses, we implemented rapid infusion protocols for selected patients. Objective: To analyse the rate of infu...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955770/ https://www.ncbi.nlm.nih.gov/pubmed/33321356 http://dx.doi.org/10.1016/j.msard.2020.102642 |